Jaume Capdevila
@ja_capdevila
Medical Oncologist focused on GI & Endocrine Malignances. Vall Hebron University Hospital. Vall Hebron Institute of Oncology (VHIO). Teknon Cancer Institute.
ID: 865242240372936704
18-05-2017 16:26:40
3,3K Tweet
2,2K Takipçi
268 Takip Edilen
PRRT vs Everolimus for 🫁 carcinoids. The ongoing phase III GETNE-LEVEL study. Bringing new hopes for patients with #neuroendocrinecancer Grupo GETNE NET- ESPAÑA NET Cancer Day CarcinoidCancer CCF ENETS NANETS Vall d’Hebron Institute of Oncology (VHIO) @https://link.springer.com/10.1186/s12885-025-13941-3